Biblio

Export 135 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is T  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
T. Tabira and Kawamura, N., “A Study of a Supplement Containing Huperzine A and Curcumin in Dementia Patients and Individuals with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 63, no. 1, pp. 75-78, 2018.
S. Taheri, Yu, J., Zhu, H., and Kindy, M. S., “High-Sodium Diet Has Opposing Effects on Mean Arterial Blood Pressure and Cerebral Perfusion in a Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1061-1072, 2016.
M. Tahmi, Rippon, B., Palta, P., Sherwood, G., Hernandez, G., Soto, L., Ceballos, F., Pardo, M., Laing, K., Igwe, K., He, H., Teresi, J. A., Moreno, H., Razlighi, Q., Brickman, A. M., and Luchsinger, J. A., “In Vivo Amyloid, Neurodegeneration, and Verbal Learning in Late Middle-Aged Hispanics.”, J Alzheimers Dis, vol. 82, no. 1, pp. 317-325, 2021.
R. Taipa, Sousa, A. Luísa, Pires, M. Melo, and Sousa, N., “Does the Interplay Between Aging and Neuroinflammation Modulate Alzheimer's Disease Clinical Phenotypes? A Clinico-Pathological Perspective.”, J Alzheimers Dis, vol. 53, no. 2, pp. 403-17, 2016.
H. Taipale, Lampela, P., Koponen, M., Tanskanen, A., Tiihonen, J., Hartikainen, S., and Tolppanen, A. - M., “Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.”, J Alzheimers Dis, vol. 68, no. 1, pp. 127-136, 2019.
W. Tajeddinn, Fereshtehnejad, S. - M., Ahmed, M. Seed, Yoshitake, T., Kehr, J., Shahnaz, T., Milovanovic, M., Behbahani, H., Höglund, K., Winblad, B., Cedazo-Minguez, A., Jelic, V., Järemo, P., and Aarsland, D., “Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers.”, J Alzheimers Dis, vol. 53, no. 2, pp. 621-30, 2016.
W. Tajeddinn, Persson, T., Calvo-Garrido, J., Ahmed, M. Seed, Maioli, S., Vijayaraghavan, S., Kazokoglu, M. Selim, Parrado-Fernández, C., Yoshitake, T., Kehr, J., Francis, P., Winblad, B., Höglund, K., Cedazo-Minguez, A., and Aarsland, D., “Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 1, pp. 349-61, 2016.
S. Takahashi, Mizukami, K., Arai, T., Ogawa, R., Kikuchi, N., Hattori, S., Darby, D., and Asada, T., “Ventilatory Response to Hypercapnia Predicts Dementia with Lewy Bodies in Late-Onset Major Depressive Disorder.”, J Alzheimers Dis, vol. 50, no. 3, pp. 751-8, 2016.
M. Takemoto, Sato, K., Hatanaka, N., Yamashita, T., Ohta, Y., Hishikawa, N., and Abe, K., “Different Clinical and Neuroimaging Characteristics in Early Stage Parkinson's Disease with Dementia and Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 52, no. 1, pp. 205-11, 2016.
S. Takenoshita, Terada, S., Yokota, O., Kutoku, Y., Wakutani, Y., Nakashima, M., Maki, Y., Hattori, H., and Yamada, N., “Sally-Anne Test in Patients with Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1029-1036, 2018.
K. Talbot, Wang, H. - Y., Kazi, H., Han, L. - Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., Arvanitakis, Z., Schneider, J. A., Wolf, B. A., Bennett, D. A., Trojanowski, J. Q., and Arnold, S. E., “Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.”, J Clin Invest, vol. 122, no. 4, pp. 1316-38, 2012.
M. T. Tam, Dosso, J. A., and Robillard, J. M., “The Impact of a Global Pandemic on People Living with Dementia and Their Care Partners: Analysis of 417 Lived Experience Reports.”, J Alzheimers Dis, vol. 80, no. 2, pp. 865-875, 2021.
E. Tamagno, Guglielmotto, M., Monteleone, D., Manassero, G., Vasciaveo, V., and Tabaton, M., “The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1241-1245, 2018.
Y. Jayne Tan, Siow, I., Saffari, S. Ehsan, Ting, S. K. S., Li, Z., Kandiah, N., Tan, L. C. S., Tan, E. King, and Ng, A. S. L., “Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition.”, J Alzheimers Dis, vol. 92, no. 2, pp. 573-580, 2023.
M. - S. Tan, Wang, P., Ma, F. - C., Li, J. - Q., Tan, C. - C., Yu, J. - T., and Tan, L., “Common Variant in PLD3 Influencing Cerebrospinal Fluid Total Tau Levels and Hippocampal Volumes in Mild Cognitive Impairment Patients from the ADNI Cohort.”, J Alzheimers Dis, vol. 65, no. 3, pp. 871-876, 2018.
B. Tan, Venketasubramanian, N., Vrooman, H., Cheng, C. - Y., Wong, T. Yin, Ikram, M. Kamran, Chen, C., and Hilal, S., “Homocysteine and Cerebral Atrophy: The Epidemiology of Dementia in Singapore Study.”, J Alzheimers Dis, vol. 62, no. 2, pp. 877-885, 2018.
E. C. K. Tan, Eriksdotter, M., Garcia-Ptacek, S., Fastbom, J., and Johnell, K., “Anticholinergic Burden and Risk of Stroke and Death in People with Different Types of Dementia.”, J Alzheimers Dis, vol. 65, no. 2, pp. 589-596, 2018.
Y. Jayne Tan, Ng, A. S. L., Vipin, A., Lim, J. K. W., Chander, R. J., Ji, F., Qiu, Y., Ting, S. K. S., Hameed, S., Lee, T. - S., Zeng, L., Kandiah, N., and Zhou, J., “Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 58, no. 2, pp. 413-423, 2017.
C. - C. Tan, Wan, Y., Tan, M. - S., Zhang, W., Wang, Z. - X., Sun, F. - R., Miao, D., Tan, L., and Yu, J. - T., “Association of Frontotemporal Dementia GWAS Loci with Late-Onset Alzheimer's Disease in a Northern Han Chinese Population.”, J Alzheimers Dis, vol. 52, no. 1, pp. 43-50, 2016.
E. C. K. Tan, J Bell, S., Lu, C. Y., and Toh, S., “National Trends in Outpatient Antihypertensive Prescribing in People with Dementia in the United States.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1425-1435, 2016.
C. - C. Tan, Zhang, X. - Y., Tan, L., and Yu, J. - T., “Tauopathies: Mechanisms and Therapeutic Strategies.”, J Alzheimers Dis, vol. 61, no. 2, pp. 487-508, 2018.
D. C. S. Tan, Yao, S., Ittner, A., Bertz, J., Ke, Y. D., Ittner, L. M., and Delerue, F., “Generation of a New Tau Knockout (tauΔex1) Line Using CRISPR/Cas9 Genome Editing in Mice.”, J Alzheimers Dis, vol. 62, no. 2, pp. 571-578, 2018.
L. Tan, Yang, H., Pang, W., Li, H., Liu, W., Sun, S., Song, N., Zhang, W., and Jiang, Y., “Investigation on the Role of BDNF in the Benefits of Blueberry Extracts for the Improvement of Learning and Memory in Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 56, no. 2, pp. 629-640, 2017.
M. - S. Tan, Zhu, J. - X., Cao, X. - P., Yu, J. - T., and Tan, L., “Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese.”, J Alzheimers Dis, vol. 64, no. 1, pp. 55-59, 2018.
R. Tandon, Levey, A. I., Lah, J. J., Seyfried, N. T., and Mitchell, C. S., “Machine Learning Selection of Most Predictive Brain Proteins Suggests Role of Sugar Metabolism in Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 2, pp. 411-424, 2023.

Pages